Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02665468 · ClinicalTrials.gov registry record · NA
eHealth Partnered Evaluation Initiative
A NA study of Non-secure Message Senders, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,196
- Enrollment target
- 4
- Study locations
NCT02665468: Completed NA study of Non-secure Message Senders, sponsored by VA Office of Research and Development.
NCT02665468 is a NA study of Non-secure Message Senders that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,196 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02665468, a NA study of Non-secure Message Senders, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,196 participants
- Enrollment target
- 4
- Study locations
Study Summary
On October 1, 2016, the VHA Office of Telehealth and the Connected Health Office will merge to create a single entity that will be responsible for the implementation and evaluation of eHealth technologies across the healthcare system. In an effort to successfully fulfill its mission, the new combined Connected Health/Telehealth Office is pledging $1,100,000 for an eHealth Partnered Evaluation Initiative (PEI) to support the further implementation of eHealth technologies across VHA, and to measure their impacts on dimensions of access and other outcomes. Developed in close consultation with leadership of the new office, the proposed objectives of the eHealth PEI are to (1) implement a patient-level "supported adoption intervention" for secure messaging and evaluate the impact of secure messaging use through a rapid, one-year randomized trial; and (2) evaluate the initial rollout of VHA's automated telehealth text messaging system to Veterans and clinical team members.
Primary Outcome
Measure the change in rate of use of secure messaging in intervention versus control Veterans, reported as participants in each arm that sent a secure message during study period.
Conditions Studied
Interventions
- BEHAVIORAL Supported adoption intervention
- BEHAVIORAL Active comparator control
Study Locations (4)
Alabama
- Birmingham VA Medical Center, Birmingham, AL - Birmingham
Massachusetts
- Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA - Bedford
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,196 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
What the finished NCT02665468 record still lists
NCT02665468 is an interventional study that assigns participants to a tested intervention. Its 1,196 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Non-secure Message Senders appearing as the primary indexed condition, and to 2 interventions - of which Supported adoption intervention is the first listed.
NCT02665468 reports a single indexed study location in Alabama, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02665468 about?
NCT02665468 is a clinical study titled "eHealth Partnered Evaluation Initiative". On October 1, 2016, the VHA Office of Telehealth and the Connected Health Office will merge to create a single entity that will be responsible for the implementation and evaluation of eHealth technologies across the healthcare system. In an effort to successfully fulfill its mission, the new combine...
What is the current status of trial NCT02665468?
This trial is currently completed. It is a NA study. The enrollment target is 1,196 participants. The study started on 2016-02-01. Estimated completion is 2017-09-30.
What conditions does trial NCT02665468 study?
This clinical trial studies the following conditions: Non-secure Message Senders.
What interventions are being tested in trial NCT02665468?
The interventions under investigation include: Supported adoption intervention (BEHAVIORAL), Active comparator control (BEHAVIORAL).
Who is sponsoring clinical trial NCT02665468?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02665468 being conducted?
This trial has 4 study locations across Alabama, Massachusetts, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02665468's enrollment target sits among peer trials
1,196 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI